Teladoc Health, Inc. (TDOC)
NYSE: TDOC · Real-Time Price · USD
6.83
-0.07 (-1.01%)
At close: Apr 17, 2025, 4:00 PM
6.83
0.00 (0.00%)
After-hours: Apr 17, 2025, 7:40 PM EDT
Teladoc Health Stock Forecast
Stock Price Forecast
The 17 analysts with 12-month price forecasts for Teladoc Health stock have an average target of 10.94, with a low estimate of 8.00 and a high estimate of 17. The average target predicts an increase of 60.18% from the current stock price of 6.83.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Teladoc Health stock from 18 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Hold | 13 | 13 | 13 | 11 | 11 | 11 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 20 | 20 | 20 | 18 | 18 | 18 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B of A Securities | B of A Securities | Hold Maintains $9.5 → $8 | Hold | Maintains | $9.5 → $8 | +17.13% | Apr 11, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $16 → $13 | Strong Buy | Maintains | $16 → $13 | +90.34% | Mar 3, 2025 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Feb 27, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $13 → $12 | Buy | Maintains | $13 → $12 | +75.70% | Feb 27, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $14 → $16 | Strong Buy | Maintains | $14 → $16 | +134.26% | Feb 18, 2025 |
Financial Forecast
Revenue This Year
2.57B
from 2.57B
Decreased by -0.02%
Revenue Next Year
2.61B
from 2.57B
Increased by 1.67%
EPS This Year
-0.95
from -5.87
EPS Next Year
-0.86
from -0.95
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 2.7B | 2.8B | 2.9B | ||
| Avg | 2.6B | 2.6B | 2.7B | ||
| Low | 2.4B | 2.4B | 2.4B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 4.1% | 7.0% | 9.2% | ||
| Avg | -0.0% | 1.7% | 2.3% | ||
| Low | -5.2% | -6.4% | -8.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.74 | -0.41 | 0.17 | ||
| Avg | -0.95 | -0.86 | -0.80 | ||
| Low | -1.34 | -1.37 | -1.29 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.